網協新聞/整理報導 101.5.24ITF日前來信通報告各國網球協會，24歲的保加利亞男子選手庫卓夫斯基(Dimitar Kutrovsky)，因檢測出使用網球項目禁藥甲基己胺(me
網協新聞/整理報導 101.5.24
ITF日前來信通報告各國網球協會，24歲的保加利亞男子選手庫卓夫斯基(Dimitar Kutrovsky)，因檢測出使用網球項目禁藥甲基己胺(methylhexaneamine)，判處禁賽兩年的處分，而檢測出有藥物反應期間所參加的兩站賽事的獎金與積分也遭追回。
庫卓夫斯基(Dimitar Kutrovsky)是在今年2月14日參加美國聖荷西SAP公開賽時檢測出甲基己胺(methylhexaneamine)反應，庫卓夫斯基則聲稱是因為飲用Jack3d補給品時攝取到的，並非刻意使用該藥物。
ITF雖然沒有質疑庫卓夫斯基的說法，但是由於庫卓夫斯基個人的疏忽，以及無法確切證明自己不是刻意用藥，認定他違反禁藥規定10.4條的規定，判決他自 2012年2月14日起禁賽兩年(至 2014年2月13日止),並決議取消庫卓夫斯基在2012 SPA 公開賽以及Brownsville 未來賽兩站賽事的參賽資格，因此他於兩站賽事所獲得的奬金和積分也宣告無效。
網球協會呼籲所有選手務必注意並確實相關規定，以維護自身權益。
以下為ITF反禁藥網站原文中英對照
---
原文網址: http://www.itftennis.com/antidoping/news/pressrelease.asp?articleid=23556
---
Decision in the case of Dimitar Kutrovsky
Mr. Dimitar Kutrovsky的判決案例
The International Tennis Federation announced today that Dimitar Kutrovsky has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s sample).
ITF今日宣告選手Dimitar Kutrovsky被發現違反禁藥2.1條款.
Mr Kutrovsky, a 24-year-old tennis player from Bulgaria , provided a sample on 14 February 2012 at the SAP Open held in San Jose , United States . That sample was sent to the WADA-accredited laboratory in Montreal , Canada for analysis, and was found to contain methylhexaneamine, a stimulant. Methylhexaneamine is a Prohibited Substance under section S6 of the 2012 WADA List of Prohibited Substances and Prohibited Methods, and is therefore also prohibited under the Tennis Anti-Doping Programme (TADP). Mr Kutrovsky was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.
來自保加利亞24歲的選手Mr. Kutrovsky在 2012/2/14於美國聖荷西參加SAP公開賽時被檢測出使用禁藥. 檢測物被送到加洲WADA實驗室分析,發現內含有methylhexaneamine(甲基己胺), 一種興奮劑的成份. 甲基己胺是被列在2012WADA第六款禁藥的條例內,也是網球項目所列禁藥.
Mr Kutrovsky asserted that the methylhexaneamine, for which he did not hold a valid therapeutic use exemption, had got into his system through his ingestion of the supplement Jack3d. He denied any intent to enhance his performance as a result of taking the Jack3d.
庫卓夫斯基聲稱被檢測到的甲基己胺並不是用於治療的, 而是在飲用Jack3d補給品時攝取到的.他否認飲用Jack3d是為了提升他的專業表現.
The ITF did not dispute Mr Kutrovsky’s account of the circumstances surrounding his ingestion of methylhexaneamine, but asserted that he had not demonstrated to the required standard that he (a) did not intend to enhance his performance, and so failed to meet the requirements to satisfy article 10.4 of the TADP (Elimination or Reduction of the Period of Ineligibility for Specified Substance under Specified Circumstances), and (b) bore No Significant Fault or Negligence.
ITF並沒有質疑Mr. Kutrovsky的說法,但聲明由於Mr. Kutrovsky的疏忽和錯誤,以及沒有辦法證明自己不是企圖想提升自己表現而飲用,因而違反TPDA10.4的規則
The tribunal concurred, and therefore confirmed Mr Kutrovsky’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme, and determined that he should be suspended from participation for a period of two years, back-dated to commence from 14 February 2012 and so ending at midnight on 13 February 2014. The tribunal also determined that Mr Kutrovsky’s results at the 2012 SAP Open and Brownsville Futures events should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at those events.
因此,法庭裁定Mr. Kutrovsky違返網球禁藥規則,判決自 2012/2/14禁賽兩年(至 2014/2/13止),並決議取消Mr. Kutrovsky於2012 SPA Open以及Brownsville Futures兩站賽事的參賽資格,因此他於兩站賽事所獲得的奬金和積分也宣告無效.
